US2009286879A1PendingUtilityA1
Preventive or Therapeutic Drug for Alzheimer-Type Dementia
Est. expiryDec 2, 2025(expired)· nominal 20-yr term from priority
Inventors:Kiyoshi Hashizume
A61P 43/00A61K 31/202A61P 25/28A61K 31/232
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
It is intended to provide a highly safe preventive or therapeutic drug for Alzheimer-type dementia which can replace the conventional therapies currently used for Alzheimer-type dementia or which can be used together with the conventional therapy to realize high therapeutic effects, characterized in that a ω-3 polyunsaturated fatty acid and thyroid hormone are used in combination.
Claims
exact text as granted — not AI-modified1 . A preventive or therapeutic drug for Alzheimer-type dementia wherein an ω-3 polyunsaturated fatty acid is used in combination with a thyroid hormone.
2 . The preventive or therapeutic drug according to claim 1 wherein the ω-3 polyunsaturated fatty acid is icosapentaenoic acid, docosahexaenoic acid, or a mixture of icosapentaenoic acid and docosahexaenoic acid.
3 . The preventive or therapeutic drug according to claim 1 wherein the ω-3 polyunsaturated fatty acid is ethyl icosapentate, ethyl docosahexaenoate, and a mixture thereof.
4 . The preventive or therapeutic drug according to claim 1 wherein the ω-3 polyunsaturated fatty acid is ethyl icosapentate.
5 . The preventive or therapeutic drug according to claim 1 wherein the thyroid hormone is levothyroxine.Join the waitlist — get patent alerts
Track US2009286879A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.